Wolters Kluwer 2014 Half-Year Report Alphen aan den Rijn,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Wolters Kluwer 2014 Half-Year Report

Alphen aan den Rijn, Netherlands, July 30, 2014 (GLOBE NEWSWIRE) -- Wolters Kluwer, a global leader in professional information services , today released its 2014 half-year results.

Highlights

  • Full-year 2014 guidance reiterated.
  • First-half revenues up 2% in constant currencies and up 1% organically.
    • Leading, growing positions (47% of total revenues) on average grew 6% organically.
    • Digital revenues (68% of total) grew 5% organically, more than offsetting print decline.
    • Digital and services revenues now account for 81% of total revenues (HY 2013: 78%)
  • First-half adjusted operating profit margin declined, as expected, due to restructuring costs.
    • Restructuring costs of €19 million in first half; continue to expect €25-30 million for full year.
  • First half diluted adjusted EPS €0.63, up 1% at constant currencies.
  • Adjusted free cash flow €136 million, up 1% at constant currencies.
  • Net-debt-to-EBITDA of 2.6x, following dividend and acquisition payments in second quarter.
  • Acquisition of Datacert in April builds on our leading growth position in Corporate Legal Services.
  • Announcing renewal of €600 million multi-currency credit facility.

Interim Report of the Executive Board

Nancy McKinstry, CEO and Chairman of the Executive Board, commented:
"In the first half of the year, we continued to build on and invest in our leading, growing positions and digital solutions, and these areas delivered sustained organic growth. Trends in Europe are still quite varied, but we are encouraged by recent performance of digital products in this region. Our planned restructuring program is well underway and we remain confident of achieving the guidance we set out at the start of the year."

Key Figures 2014 Half-Year

Six months ended June 30
(in millions of euros, unless otherwise stated)
2014 2013 D D CC D OG
Business performance - benchmark figures          
Revenues 1,716 1,742 -1% +2% +1%
Adjusted operating profit 313 334 -6% -3% -4%
Adjusted operating profit margin (%) 18.2% 19.2%      
Adjusted net profit 190 197 -4% +1%  
Diluted adjusted EPS (€) 0.63 0.66 -4% +1%  
Adjusted free cash flow 136 140 -3% +1%  
Net debt 2,227 2,276 -2%    
IFRS results 1          
Revenues 1,716 1,742 -1%    
Operating profit 214 285 -25%    
Profit for the period 2 200 164 +23%    
Diluted EPS (€) 2 0.67 0.55 +23%    
Net cash from operating activities 188 199 -6%    

D - % Change; D CC - % Change constant currencies (EUR/USD 1.33); D OG - % Organic growth. Benchmark and IFRS figures are for continuing operations unless otherwise noted. Benchmark figures are performance measures used by management. See Note 5 of this Interim Financial Report for a reconcilation from IFRS to benchmark figures. 1) International Financial Reporting Standards as adopted by the European Union. 2) Includes discontinued operations in 2013.

Full-Year 2014 Outlook

We reiterate the full-year guidance set out in February this year. Our full-year 2014 margin guidance includes anticipated restructuring costs of €25-€30 million, of which €19 million occurred in the first half. The table below provides our 2014 guidance.

Pe r f ormance indicators 201 4 Guidance
Adjusted operating profit margin 20.5%-21.5%
Adjusted free cash flow >= €475 million
Return on invested capital >= 8%
Diluted adjusted EPS Low single-digit growth

Guidance for adjusted free cash flow and diluted adjusted EPS is in constant currencies (EUR/USD 1.33).

Our guidance is based on constant exchange rates. Wolters Kluwer generates more than half of its revenue and adjusted operating profit in North America. As a rule of thumb, based on our 2013 currency profile, a 1 U.S. cent move in the average EUR/USD exchange rate for the year causes an opposite 1.0 euro-cent change in adjusted diluted EPS.

Our guidance assumes no significant change in the scope of operations. We may make further disposals which could be dilutive to margins and earnings in the near term. Additional information underlying our guidance is provided in the table below.

Additional information  
Adjusted net financing costs 1 Approximately €100 million
Benchmark effective tax rate 27.5%-28.0%
Cash conversion ratio Approximately 95%

1) In constant currencies (EUR/USD 1.33).

About Wolters Kluwer  
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2013 annual revenues of €3.6 billion. The group serves customers in over 150 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information about our products and organization, visit www.wolterskluwer.com , follow @Wolters_Kluwer on Twitter , or search for Wolters Kluwer videos on YouTube .

Calendar

November 5, 2014 Third-Quarter 2014 Trading Update
February 18, 2015      Full-Year 2014 Results
Media Investors/Analysts
Caroline Wouters Meg Geldens
Corporate Communications       Investor Relations
t + 31 (0)172 641 459 t + 31 (0)172 641 407
press@wolterskluwer.com ir@wolterskluwer.com

Forward-looking Statements
This report contains forward-looking statements. These statements may be identified by words such as "expect", "should", "could", "shall" and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

The full press release on the 2014 Half-Year Results is available here:

Wolters Kluwer 2014 Half-Year Report http://hugin.info/130682/R/1842711/641442.pdf

HUG#1842711

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 337

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 296

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 416

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 195

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 271

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 260

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 267

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading

Top 5 Most Recently Viewed Articles

Mesirow Recognized Among Top Money Management Workplaces Again

Updated Category News Views 156

Mesirow's Remarkable Recognition in Money Management Mesirow has just been honored by Pensions & Investments as a Best Places to Work in Money Management for the year 2025, marking the seventh occasion the firm has received this prestigious recognition. This accolade reflects Mesirow's unwavering commitment to fostering a workplace that prioritizes culture, employee...

Continue Reading
Follett and Bath & Body Works Team Up for Campus Retail Revolution

Updated Category News Views 275

Follett Higher Education Partners with Bath & Body Works This happy collaboration marks Follett Higher Education's new venture to enrich student life on college campuses across the nation. Follett, recognized as North America's largest campus retailer, is working with Bath & Body Works to bring their beloved bath and body products directly to students at more than 150...

Continue Reading
Understanding Recent Share Transactions of Planisware SA

Updated Category News Views 125

Overview of Planisware's Recent Share Transactions Planisware SA has recently undergone several notable transactions concerning its own shares. As a leader in project portfolio management software, the company's activities on the share market reflect its strong position and proactive approach in satisfying investor interests. Company Details Planisware SA is widely...

Continue Reading
Investor Alert: Lawsuit Against Iris Energy Limited Explained

Updated Category News Views 112

Overview of the Investor Lawsuit Against Iris Energy Limited The legal landscape for investors can often be complex, especially when serious allegations are involved. Recently, the national securities law firm, Faruqi & Faruqi, LLP, has initiated an investigation targeting Iris Energy Limited (NASDAQ: IREN) concerning potential securities law violations. The firm is...

Continue Reading
Warner Bros. Discovery Welcomes Anton Levy to Board

Updated Category News Views 166

Warner Bros. Discovery Welcomes Anton Levy to the Board Warner Bros. Discovery, Inc. (NASDAQ: WBD) is thrilled to announce the upcoming addition of Anton Levy to its Board of Directors as an independent member. This decision is part of the company's commitment to building a strong leadership team aimed at navigating the evolving media landscape. Anton Levy: A Wealth of...

Continue Reading